Axon Capital’s Humana HUM Stock Holding History

Axon Capital’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,400	Closed	-$1.04M	–	9
2022 Q1	$1.04M	Buy	+2,400	New	+$1M	2.42%	5
2019 Q3	$5.7M	Sell	22,300 -5,200	-19%	-$1.46M	15.22%	3
2019 Q2	$7.3M	Buy	+27,500	New	+$6.97M	15.23%	3

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Axon Capital's HUM Position: Q2 2022 in Review

Axon Capital sold out of Humana (HUM) in Q2 2022, closing a stake of 2,400 shares — an estimated $1.04M sold.

Axon Capital first reported a position in HUM in Q2 2019 and held it in 3 quarters. The position peaked at $7.3M in Q2 2019. 959 funds tracked by Wall St. Rank hold HUM as of Q2 2022.

Axon Capital reported no remaining Humana position as of Q2 2022 after selling out during the quarter.
Axon Capital sold 2,400 Humana shares in Q2 2022, an estimated $1.04M.
Axon Capital first reported a position in Humana in Q2 2019 and held it in 3 quarters.
Axon Capital's Humana position peaked at $7.3M in Q2 2019.
959 funds tracked by Wall St. Rank held Humana as of Q2 2022.

Based on Axon Capital's 13F filing for Q2 2022, filed 10 Aug 2022.